Latest debt-to-equity ratio
NewAmsterdam Pharma Debt-to-equity ratio
Direct answer
NewAmsterdam Pharma's debt-to-equity ratio is 0.01%.
The verified market snapshot reports 0.01%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free NewAmsterdam Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 0.01%
Explore related company data
View NewAmsterdam Pharma's market capitalizationView NewAmsterdam Pharma's price-to-book ratioView NewAmsterdam Pharma's return on equityView NewAmsterdam Pharma's dividend yieldView NewAmsterdam Pharma's 52-week price rangeView NewAmsterdam Pharma's revenue growthView NewAmsterdam Pharma's profit marginView all NewAmsterdam Pharma key metricsReturn to NewAmsterdam Pharma profile